Disease progression modeling of Alzheimer's disease according to education level

被引:19
|
作者
Kim, Ko Woon [1 ,2 ,3 ,4 ]
Woo, Sook Young [5 ]
Kim, Seonwoo [5 ]
Jang, Hyemin [1 ,6 ]
Kim, Yeshin [1 ,7 ]
Cho, Soo Hyun [1 ,8 ]
Kim, Si Eun [1 ,9 ]
Kim, Seung Joo [1 ,10 ,11 ]
Shin, Byoung-Soo [2 ,3 ,4 ]
Kim, Hee Jin [1 ,6 ]
Na, Duk L. [1 ,6 ,12 ,13 ]
Seo, Sang Won [1 ,12 ,13 ,14 ]
机构
[1] Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Sch Med, 81 Irwon Dong, Seoul 06351, South Korea
[2] Jeonbuk Natl Univ Hosp, Sch Med, Dept Neurol, Jeonju, South Korea
[3] Jeonbuk Natl Univ, Res Inst Clin Med, Jeonju, South Korea
[4] Jeonbuk Natl Univ Hosp, Biomed Inst, Jeonju, South Korea
[5] Samsung Med Ctr, Stat & Data Ctr, Seoul, South Korea
[6] Samsung Med Ctr, Neurosci Ctr, Seoul, South Korea
[7] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Dept Neurol, Coll Med, Chunchon, South Korea
[8] Chonnam Natl Univ, Dept Neurol, Med Sch & Hosp, Gwangju, South Korea
[9] Inje Univ, Haeundae Paik Hosp, Dept Neurol, Coll Med, Busan, South Korea
[10] Gyeongsang Natl Univ, Dept Neurol, Sch Med, Chang Won, South Korea
[11] Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea
[12] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea
[13] Samsung Med Ctr, Samsung Alzheimer Res Ctr, Seoul, South Korea
[14] Sungkyunkwan Univ, Dept Intelligent Precis Healthcare Convergence, Sch Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
MILD COGNITIVE IMPAIRMENT; DECLINE; DEMENTIA; DIAGNOSIS; SCALE;
D O I
10.1038/s41598-020-73911-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
To develop a disease progression model of Alzheimer's disease (AD) that shows cognitive decline from subjective cognitive impairments (SCI) to the end stage of AD dementia (ADD) and to investigate the effect of education level on the whole disease spectrum, we enrolled 565 patients who were followed up more than three times and had a clinical dementia rating sum of boxes (CDR-SB). Three cohorts, SCI (n=85), amnestic mild cognitive impairment (AMCI, n=240), and ADD (n=240), were overlapped in two consecutive cohorts (SCI and AMCI, AMCI and ADD) to construct a model of disease course, and a model with multiple single-cohorts was estimated using a mixed-effect model. To examine the effect of education level on disease progression, the disease progression model was developed with data from lower (<= 12) and higher (>12) education groups. Disease progression takes 274.3 months (22.9 years) to advance from 0 to 18 points using the CDR-SB. Based on our predictive equation, it takes 116.5 months to progress from SCI to AMCI and 56.2 months to progress from AMCI to ADD. The rate of CDR-SB progression was different according to education level. The lower-education group showed faster CDR-SB progression from SCI to AMCI compared to the higher-education group, and this trend disappeared from AMCI to ADD. In the present study, we developed a disease progression model of AD spectrum from SCI to the end stage of ADD. Our disease modeling provides us with more understanding of the effect of education on cognitive trajectories.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Low-Level Laser Therapy Ameliorates Disease Progression in a Mouse Model of Alzheimer's Disease
    Farfara, Dorit
    Tuby, Hana
    Trudler, Dorit
    Doron-Mandel, Ella
    Maltz, Lidya
    Vassar, Robert J.
    Frenkel, Dan
    Oron, Uri
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2015, 55 (02) : 430 - 436
  • [42] Low-Level Laser Therapy Ameliorates Disease Progression in a Mouse Model of Alzheimer’s Disease
    Dorit Farfara
    Hana Tuby
    Dorit Trudler
    Ella Doron-Mandel
    Lidya Maltz
    Robert J. Vassar
    Dan Frenkel
    Uri Oron
    Journal of Molecular Neuroscience, 2015, 55 : 430 - 436
  • [43] SYSTEMATIC REVIEW OF BIOMARKERS FOR DISEASE PROGRESSION IN ALZHEIMER'S DISEASE
    McGhee, David
    Counsell, Carl
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [44] A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
    McGhee, David J. M.
    Ritchie, Craig W.
    Thompson, Paul A.
    Wright, David E.
    Zajicek, John P.
    Counsell, Carl E.
    PLOS ONE, 2014, 9 (02):
  • [45] Cholinesterase inhibitors affect disease progression in Alzheimer's disease
    Marini, S.
    Bessi, V.
    Padiglioni, S.
    Nacmias, B.
    Bagnoli, S.
    Sorbi, S.
    Bracco, L.
    JOURNAL OF NEUROLOGY, 2013, 260 : S165 - S165
  • [46] Cardiovascular Disease Risk Factors and Progression of Alzheimer's Disease
    van Kan, Gabor Abellan
    Rolland, Yves
    Nourhashemi, Fati
    Coley, Nicola
    Andrieu, Sandrine
    Vellas, Bruno
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (03) : 240 - 246
  • [47] DISEASE PROGRESSION IN ALZHEIMER'S DISEASE: CAN WE CHANGE IT?
    Wilkinson, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 658 - 658
  • [49] Longitudinal Exposure—Response Modeling of Multiple Indicators of Alzheimer’s Disease Progression
    D. G. Polhamus
    Michael J. Dolton
    J. A. Rogers
    L. Honigberg
    J. Y. Jin
    A. Quartino
    The Journal of Prevention of Alzheimer's Disease, 2023, 10 : 212 - 222
  • [50] Modeling Alzheimer's Disease Progression with Fused Laplacian Sparse Group Lasso
    Liu, Xiaoli
    Cao, Peng
    Goncalves, Andre R.
    Zhao, Dazhe
    Banerjee, Arindam
    ACM TRANSACTIONS ON KNOWLEDGE DISCOVERY FROM DATA, 2018, 12 (06)